REVIEW PAPER
Early and long-term complications in haemodialysis vascular access
Submission date: 2018-06-17
Acceptance date: 2018-08-02
Publication date: 2018-12-31
Medical Studies 2018;34(4):342-348
KEYWORDS
TOPICS
ABSTRACT
The paper presents vascular accesses used for the purpose of haemodialysis in patients with end-stage renal disease. The recommendations of the NKF K/DOQI concern performing a first-time permanent access in the form of an autogenous fistula. Attention has been paid to accurate diagnostic imaging of blood vessels. Early and long-term complications of functioning fistulas are presented, together with the manner of their treatment. Dialysis catheters are also described as the only possibility of dialysis in patients with contraindications to the creation of fistulas. Bloodstream infections are the most common complication of dialysis with catheters. An important element of prevention is monitoring the function of catheters, which reduces the need for medical intervention. New solutions improving the functioning of vascular access have also been presented. Careful use of vascular access, as well as fistula and catheter site function monitoring, contributes to extending the lifespan of an access and reduces complications.
REFERENCES (22)
1.
Mączyńska B, Przondo-Mordarska A. Bloodstream infections related to venous access. Your Health Warsaw, Infection 2011; 4.
2.
Hsiao PJ, Tsai MH, Leu JG, Fang YW. Iliopsoas abscess as a complication of tunneled jugular vein catheterization in a haemodialysis patient. Hemodial Int 2015; 19: 330-2.
4.
Vascular access to dialysis. Chęciński P, Czekalski S, Oszkinis G, Zapalski S (eds). Urban & Partner, Wroclaw 2001.
6.
Weyde W, Krajewska M, Klinger M. Vascular access to hemodialysis. Nephrol Forum 2008; 1: 119-26.
7.
New Data on TVA Medical’s everlinQ endoAVF System for Endovascular Hemodialysis Access Presented at LINC 2017, Endovascular Today, Jan. 26, 2017; http://evtoday.com/2017/01/new....
8.
Brala M, Kamiński R, Trudnowski S, Grzybiak M, Kozłowski D, Raczak G. Long-term complications after implantation of catheters for hemodialysis. Geriatrics 2014; 8: 1-5.
9.
Yoon WJ, Lorelli DR. Two-stage hemodialysis Reliable Outflow (HeRO) graft implantation technique that avoids the use of a femoral bridging dialysis catheter. J Vasc Access 2015; 16: 64-7.
10.
Chemla E, Velazquez CC, D’Abate F, Ramachandran V, Maytham G. Arteriovenous fistula construction with the VasQTM external support device: a pilot study. J Vasc Access 2016; 17: 243-8.
11.
Oun HA, Price AJ, Traynor JP. Scott Infective endocarditis in patients on haemodialysis – possible strategies for prevention. Scott Med J 2016; 61: 97-102.
12.
Lima JK, Lima SR, de Lima AL Jr, Agra CV, Valenti VE, Gomes RL, Rodrigues LM, Correa JA, Raimundo RD, de Abreu LC. Double-lumen catheter in the right jugular vein induces two sub-endothelial abscesses in an unusual place, the transition between the superior vena cava and the right atrium: a case report. Int Arch Med 2014; 7: 37.
13.
Thakar S, Janga KC, Tolchinsky T, Greenberg S, Sharma K, Sadiq A, Lichstein E, Shani J. Superior vena cava and right atrium wall infective endocarditis in patients receiving hemodialysis. Heart Lung 2012; 41: 301-7.
14.
Grothe C, da Silva Belasco AG, de Cássia Bittencourt AR, Vianna LA, de Castro Cintra Sesso R, Barbosa DA. Incidence of bloodstream infection among patients on hemodialysis by central venous catheter. Rev Lat Am Enfermagem 2010; 18: 73-80.
15.
Lafrance JP, Rahme E, Lelorier J, Iqbal S. Vascular access related infections: definitions, incidence rates, and risk factors. Am J Kidney Dis 2008; 52: 982-93.
16.
Bialobrzeska B. How to care for vascular access to hemodialysis (part 2). Nephrol Forum 2009; 2: 266-74.
17.
Magrian G. Application of modern anticoagulants in the care of permanent catheters. Nephrol Forum 2008; 1: 152-5.
18.
O’Grady NP, Alexander M, Burns LA, Dellinger PA, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph A, Rupp ME, Saint S, and Healthcare Infection Control Practices Advisory Committee (HICPAC). CDC Guidelines for the Prevention of Intravascular Catheter-Related Infection,2011; https://www.cdc.gov/infectionc... guidelines/bsi/.
19.
Thomas N. Renal nursing. Baillere Tindall. ed. 2. Elsevier, United Kingdom 2002; 171-205.
20.
Myśliwiec M, Zdrojewski Z. Anticoagulant management in hemodialysis and related techniques. In: Renal Replacement Therapy. Rutkowski B (ed.). Czelej, Lublin 2007; 81-8.
21.
Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ; CITRATE Study Group. Randomized clinical trial comparison of trisodium citrate 30% and heparin as catheter locking solution in hemodialisis patients. J Am Soc Nephrol 2005; 16: 2769-77.
22.
Winnicki W, Herkner H, Lorentz M, Handisurya A, Kikić Ž, Bielesz B, Schairer B, Reiter T, Eskandary F, SunderPlassmann G, Sengoelge G. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney Int 2018; 93: 753-60.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
